How to appeal an Elevance Health adult adhd medications denial
ACA §2719 + ERISA §503 · 180-day window · 30-day decision
To appeal an Elevance Health adult adhd medications denial, file an internal appeal within 180 days of the date on the denial letter through Elevance Health's member or provider portal, under ACA §2719 + ERISA §503. Elevance Health returns standard decisions in 30 days; if it upholds the denial you can request an independent external review within 4 months.
The framework that applies to your appeal
Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.
Elevance Health-specific note: Operates Anthem BCBS in 14 states. Owns Carelon (formerly AIM) which manages utilization for specialty drugs and advanced imaging. State complaint route is to the state insurance department where the policy was issued.
What Elevance Health's policy requires for adult adhd medications
Cited policy: BCBS Prior Authorization Criteria — ADHD/Stimulant Medications (varies by plan; e.g., Anthem CG-MED-ADHD, Highmark Stimulants PA)
Wide variation. Most require DSM diagnosis, prior trial of >=1 generic stimulant for brand, dose within FDA label.
How Elevance Health denies adult adhd medications — and how to counter it
Where Elevance Health pushes back: 1) Adult new-start denials with 'ADHD typically diagnosed in childhood'; 2) Dose cap denials for Vyvanse >70mg or Adderall XR >30mg; 3) Concurrent benzodiazepine or opioid use flagged as contraindication.
Counter-arguments that hold up: World Federation of ADHD Consensus 2021 — adult-onset recognition is valid; late diagnosis common in women and high-IQ individuals who compensated. For doses above label: peer-reviewed dose-response (Wigal et al. on Vyvanse, Spencer et al. on amphetamine) — request medical exception with clinical justification. Stimulant + benzodiazepine NOT contraindicated; only requires monitoring per FDA label.
What Elevance Health typically denies for adult adhd medications
Across Elevance Health's commercial and Medicare books, denials cluster around a small number of patterns. For adult adhd medications, expect:
- Step therapy
- Medical necessity for biologics
- Out-of-network for behavioral health
- Bariatric surgery prior auth
Treatments most often denied in this category
These are the adult adhd medications treatments most often flagged for prior auth, step therapy, or medical necessity review:
- Vyvanse
- Adderall XR
- Concerta
- Focalin XR
- Ritalin LA
- Strattera
How to submit the appeal to Elevance Health
- Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
- Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document Elevance Health cited in the denial.
- File the appeal through Elevance Health's portal (members: https://www.anthem.com ; providers: https://providers.anthem.com). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
- If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In IN, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.
Clinician or prior-auth team handling this on the practice side? See Elevance Health's prior-authorization criteria by drug: Elevance Health PA criteria on ApprovalHelp.
Frequently asked questions
How long do I have to appeal an Elevance Health adult adhd medications denial?
Elevance Health allows 180 days from the date on the denial letter to file an internal appeal. Standard decisions come back within 30 days; expedited decisions for urgent care typically within 72 hours.
What's the fastest way to submit an Elevance Health appeal?
Members can submit through the Elevance Health member portal at https://www.anthem.com. Providers should use the provider portal at https://providers.anthem.com. Faxed and mailed appeals are accepted but take longer.
What denials does Elevance Health most often issue for adult adhd medications?
For adult adhd medications, Elevance Health most often denies on: 1) Adult new-start denials with 'ADHD typically diagnosed in childhood'; 2) Dose cap denials for Vyvanse >70mg or Adderall XR >30mg; 3) Concurrent benzodiazepine or opioid use flagged as contraindication. The strongest counters: World Federation of ADHD Consensus 2021 — adult-onset recognition is valid; late diagnosis common in women and high-IQ individuals who compensated. For doses above label: peer-reviewed dose-response (Wigal et al. on Vyvanse, Spencer et al. on amphetamine) — request medical exception with clinical justification. Stimulant + benzodiazepine NOT contraindicated; only requires monitoring per FDA label.
What if Elevance Health denies the appeal too?
After an internal appeal denial you have the right to an external review by an independent reviewer (IRO) — request it within 4 months of the final internal denial.
Related appeal guides
Start your Adult ADHD medications appeal
Upload your Elevance Health denial letter — DenialHelp drafts a physician-ready appeal in five minutes, aligned to ACA §2719 + ERISA §503.
Get started →Contact: hello@denialhelp.com